Selleck Chemicals - Model A2664 -Rontalizumab (Anti-IFNa1)

Rontalizumab (Anti-IFNa1) is a humanized IgG1 monoclonal antibody targets IFN-α. It can be used for the research of systemic lupus erythematosus. MW :150 KD.